Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN113429349A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113429349A details a heterogeneous copper-catalyzed route for 2-trifluoromethyl benzimidazoles, offering scalable pharma intermediate production with recyclable catalysts.
Patent CN113429349A details a heterogeneous copper-catalyzed route for high-purity benzimidazoles, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel heterogeneous catalytic method for benzimidazole synthesis offering mild conditions and recyclable catalysts for cost-effective production.
Novel Cu/g-C3N4 catalyzed route offers high yields and recyclability for trifluoromethyl benzimidazole intermediates, ensuring cost-effective supply chain solutions.
Novel Cu/g-C3N4 catalytic route for high-purity benzimidazole intermediates. Offers mild conditions, recyclable catalyst, and significant cost reduction potential.
Patent CN113429349A reveals a recyclable Cu/g-C3N4 method for high-yield benzimidazole synthesis, offering cost-effective pharma intermediate solutions.
Patent CN113429349A details a Cu/g-C3N4 catalyzed route for high-purity benzimidazoles, offering scalable production and cost-effective manufacturing solutions.
Patent CN113429349A details a novel Cu/g-C3N4 catalyzed route for 2-trifluoromethyl benzimidazoles, offering mild conditions and recyclable catalysts for cost-effective API intermediate manufacturing.